Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story.
Anca Pantea StoianDoina CatrinoiuManfredi RizzoAntonio CerielloPublished in: Diabetes/metabolism research and reviews (2020)
Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action. People with diabetes are more prone to severe outcome if affected by COVID-19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxychloroquine in diabetes deserves particular attention for its documented hypoglycemic action.